Patients with orthopedic and autoimmune conditions expect Hospital for Special Surgery (HSS)–because of its leadership role–to deliver the highest quality care. To further accomplish this mission, HSS is announcing the creation of a Quality Research Center with an innovative structure for applying research methodologies to health-care quality issues.

Boehringer Ingelheim announced that the European Commission has approved MICARDIS® (telmisartan) for the reduction of cardiovascular morbidity in patients with:
I. manifest atherothrombotic cardiovascular disease (history of coronary heart disease, stroke, or peripheral arterial disease) or,

Physical exercise is one of the most effective methods of preventing disease. The current issue of Deutsches Arzteblatt International (Dtsch Arztebl Int 2009; 106[40]: 713 – 27) is devoted to this important topic.

UCSF HIV researchers have received two NIH grants of $1 million each to study the use of web-based, patient controlled personal health records to improve health and HIV prevention outcomes for HIV positive patients.

Sustaining modest weight loss for 10 years, or taking an anti-diabetic drug over that time, can prevent or lower the incidence of type 2 diabetes in people at high risk for developing the disease, according to the Diabetes Prevention Program Outcomes Study (DPPOS), a long-term follow-up to a landmark 2001 diabetes prevention study.